![]() |
市場調查報告書
商品編碼
1781174
跳蚤·扁虱驅除產品的全球市場,各產品類型,寵物的類別,寄生蟲,各流通管道,各地區,機會,預測,2018年~2032年Global Flea and Tick Product Market Assessment, By Product Type, By Pet Type, By Parasite, By Distribution Channel, By Region, Opportunities, and Forecast, 2018-2032F |
全球跳蚤和扁虱防治產品市場預計將從 2024 年的 80.4 億美元成長至 2032 年的 144 億美元,預測期內(2025-2032 年)的複合年增長率為 7.56%。這主要得益於寵物擁有量的成長、人畜共通傳染病意識的增強以及蟲害防治解決方案的進步。其中一個驅動因素是寵物擁有量的成長和寵物人性化。越來越多的人收養寵物並將其視為家庭成員,這導致寵物健康支出增加。人們對萊姆病和埃立克體病等跳蚤和扁虱傳播疾病的認識不斷提高,促使寵物主人尋求預防性治療,獸醫也開出了全年預防的處方,而不是季節性用藥。氣候變遷也在推動這個市場的發展,因為氣溫升高延長了寄生蟲的棲息地和活動期,增加了寵物接觸寄生蟲的風險。
產品創新是市場成長的主要驅動力,易於服用的口服片劑、長效項圈和天然替代品等創新產品佔據了市場主導地位。電子商務和寵物護理零售業的成長使這些產品比以往任何時候都更容易獲得,訂閱模式鼓勵人們定期使用。可支配收入的成長,尤其是在新興市場,也支撐了需求,推動了寵物醫療保健支出的增加和寵物保險的普及。醫生的建議發揮關鍵作用,專家推薦處方級藥物,而新活性成分的監管批准正在增強消費者信心。此外,對跳蚤和扁虱傳播的人畜共通傳染病(例如落磯山斑疹熱)的擔憂也推動了對預防解決方案的需求。展望未來,基於人工智慧的害蟲追蹤等新技術、客製化的寵物醫療保健解決方案以及亞太和拉丁美洲的市場成長可能會進一步推動產業成長。
例如,2023年8月,勃林格殷格翰國際有限公司宣佈在印度拓展NexGard(阿福拉納)S和M的市場。此次擴張是繼NexGard X和L上市之後,進一步擴展了NexGard針對小型犬(2-4公斤)和中型犬(4-10公斤)的產品線。
以上公司非基於市場佔有率排序,並且可能會根據研究過程中可用的信息而變化。
Global flea and tick product market is projected to witness a CAGR of 7.56% during the forecast period 2025-2032, growing from USD 8.04 billion in 2024 to USD 14.40 billion in 2032, owing to a combination of increasing pet ownership, rising awareness of zoonotic diseases, and advancements in pest control solutions. Among the drivers is increased pet ownership and humanization of pets, as more people own pets and treat them as family, contributing to increased expenditure on pet health. Increased sensitization about flea and tick-borne diseases, including Lyme disease and ehrlichiosis, has also led to pet owners demanding preventive treatment, with veterinarians prescribing year-round protection rather than seasonal use. Climate change is another driver, with warmer temperatures increasing the range and activity seasons of parasites, raising exposure risks for pets.
Product innovation has been a primary market growth driver, with innovations such as easy-to-administer oral pills, long-lasting collars, and natural alternatives commanding a dominant share. Growth of e-commerce and pet care retail has made these products more accessible than ever, while subscription models encourage regular usage. Rising disposable income, particularly in developing markets, has also supported demand, aided by rising expenditure on pet healthcare and growing acceptance of pet insurance. Doctor recommendations play an important role, with such experts recommending prescription-grade medication, while regulatory clearances of new active ingredients enhance consumer confidence. Furthermore, fears of zoonotic diseases spread by fleas and ticks, such as Rocky Mountain spotted fever, have also supported demand for preventive solutions. In the future, new technologies such as AI-based tracking of pests, customized pet healthcare solutions, and market growth in Asia-Pacific and Latin America are likely to fuel the industry's growth even further.
For instance, in August 2023, Boehringer Ingelheim International GmbH announced its expansion of NexGard (afoxolaner) S and M markets in India. The expansion comes after the launch of NexGard X and L and expands the NexGard product line for small (2-4 kg) and medium (4-10 kg) dogs.
Rising Pet Ownership and Humanization of Pets Drives the Global Flea and Tick Product Market Demand
The growing trend of pet ownership and the humanization of pets are key drivers of the demand seen in the global flea and tick product market. As more families embrace pet adoption, especially in the post-COVID-19 era, companion animals are considered part of the family, with more financial investment in their health and wellness. The change in attitude has raised awareness of the importance of pet care, especially protection from fleas and ticks, which trigger distress and disease transmission. As pets are taking a more central position in the family, owners are increasingly turning to a proactive approach in preventive care, seeking veterinarian-approved treatments for fleas and ticks. With the pet humanization trend showing no signs of slowing, the flea and tick product market is poised to see steady growth, fueled by increasing pet care spending and intense focus on the health and safety of pets.
For instance, in May 2025, FurLife Canine Essentials LLC introduced two new products, the FurLife flea and tick shampoo for dogs and cats and FurLife flea and tick spray for dogs and cats. They are natural, plant-powered alternatives that provide effective chemical-free protection against fleas, ticks and ear mites for pets at any stage of life.
Growing Awareness of Flea and Tick-Borne Diseases Expands Global Flea and Tick Product Market Size
The increasing recognition of the health implications of flea- and tick-borne diseases is driving the growth of the global flea and tick product market. Healthcare practitioners and pet guardians are becoming more conscious of diseases like lyme disease, ehrlichiosis, and anaplasmosis that can affect humans and animals. This is additional knowledge, driven by veterinary advice and public health promotion, that has led to more comprehensive year-round prevention treatments, rather than seasonal application. The zoonotic potential of these parasites has generated increased demand, with consumers wanting to protect their pets and families from infection. Pharmaceutical development, in the form of advanced oral preventatives and long-acting topical treatments, is becoming more popular as pet owners increasingly prioritize efficacy and convenience. Education campaigns from market participants and animal welfare groups continue to highlight the need for ongoing parasite control and thus drive market expansion. As recognition of vector-borne diseases gathers momentum and preventive medicine becomes the norm, the flea and tick product market are set to grow faster, with manufacturers developing increasingly advanced solutions to meet changing consumer needs.
For instance, in July 2025, MSD Animal Health announced the United States FDA approval of Bravecto Quantum (fluralaner for extended-release injectable suspension) for dogs. This innovative injectable provides 12-month protection against most tick species and fleas (representing a significant step forward in convenience for pet owners.
Dog Segment Dominates the Global Flea and Tick Product Market
Global flea and tick product market is dominated largely by the dog segment, and it commands the largest share owing to several vital factors. One of the favorite companion animals in the world, dogs are more vulnerable to flea and tick infestations than other companion animals owing to their outdoor lifestyle and their closer exposure to environments where such parasites are most likely to flourish. The increased exposure has witnessed a high demand for prevention and treatment products specifically designed for the canines. Companies concentrate on products specifically designed for dogs, with a broad range of choices made available, such as spot-on products, oral chewable, medicated collars, and shampoos. The segment captures high compliance rates among pet owners, supported by veterinarian advice that promotes year-round parasite prevention. The pet humanization trend has also supported higher expenditure on the health of dogs, further driving market growth. With ongoing innovations in canine flea and tick control and rising dog ownership throughout the world, the segment is predicted to continue dominating, solidifying its position as the growth driver in the flea and tick product market.
For instance, in April 2025, MSD Animal Health (UK subsidiary) received marketing authorization from the Veterinary Medicines Directorate (VMD) for Bravecto TriUNO. This new monthly chewable formulation for dogs' targets both internal and external parasites, offering comprehensive protection in one convenient dose.
North America Region Leads the Global Flea and Tick Product Market
The North American market is recognized as the top leader in the global flea and tick product market with the largest market share. This leadership is a result of several key factors that together facilitate enormous market growth. The region initially has extremely high rates of pet ownership, particularly in the United States, where over half of household's own pets. This condition provides a significant customer base for flea and tick preventatives. Further, the highly advanced pet humanization culture in North America also drives demand further as pet owners increasingly seek high-end healthcare products for their pet animals. The market is also aided by advanced veterinary infrastructure as well as a shared awareness of zoonotic diseases that parasites can transfer. Routine trips to the veterinarian and preventive healthcare have become standard practice, with veterinarians actively recommending year-round flea and tick protection. Further, North America is an innovation center for products controlling fleas and ticks, with several leading industry players based there. As pet healthcare expenditure continues to increase and product development progresses, North America is well positioned to continue its leading role in the global flea and tick product market in the near term.
For instance, in May 2025, Central Garden & Pet Company launched ADAMS Botanicals Flea & Tick Pet & Home Spray. This new EPA-approved, plant-based spray for dogs, cats, pet bedding, and home surfaces marks the brand's 50th anniversary.
Impact of the U.S. Tariff on Global Flea and Tick Product Market
The imposition of U.S. tariffs on imported goods, including pet care products, has created significant ripple effects across the global flea and tick product market. As the largest consumer of these products, U.S. trade policies directly influence pricing, supply chains, and competitive dynamics worldwide.
Tariffs on raw materials (e.g., active pharmaceutical ingredients from China and India) and finished goods have raised manufacturing costs.
Companies may pass these costs to consumers, leading to higher retail prices for flea and tick treatments, particularly for budget-conscious pet owners.
Manufacturers reliant on imported ingredients face delays and increased logistical expenses.
Key Players Landscape and Outlook
The global flea and tick product market is characterized by intense competition among leading pharmaceutical companies, insurgent innovators, and private-label companies, each pursuing different strategies to capture market share. Industry leaders dominate with their market-leading brands, supported by high research and development spending and extensive veterinary networks. Brands continue to reassert themselves in the market with innovation in oral preventatives and strategic forays in emerging markets. In the near term, the market is likely to witness seismic change through the expected expirations of patents on market-leading brands, which is expected to precipitate the launch of generics and increase price competition. The trend towards combination products with multi-parasite protection is gaining traction, driven by consumer convenience preference and the manufacturers' desire to achieve higher profit margins. As the market continues to evolve, the dynamic between incumbent players and agile disruptors will shape the competitive landscape of the future, with innovation and strategic agility emerging as key determinants in this rapidly evolving landscape.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.